sTREM-1, sTREM-2, Presepsin, and Periodontitis
Comparison of sTREM-1, sTREM-2, Presepsin, and Its Association With Periodontitis: A Randomized Controlled Three-Blinded Clinic Study
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this observational study is to compare saliva sTREM-1, sTREM-2, Presepsin levels and sTREM-1/sTREM-2 ratio of participants with/without periodontitis. The main question it aims to answer is there a relationship between saliva sTREM-1, sTREM-2, Presepsin levels, sTREM-1/sTREM-2 ratio and periodontitis. Participants will give saliva samples without any intervention
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2023
CompletedFirst Posted
Study publicly available on registry
June 29, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJanuary 30, 2024
January 1, 2024
2 months
June 21, 2023
January 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sTREM-1, sTREM-2, Presepsin
sTREM-1, sTREM-2, Presepsin levels in saliva
0-1 hours of the diagnosis
Study Arms (2)
Healthy
participants without periodontitis
periodontitis
participants with stage-3 periodontitis
Interventions
Eligibility Criteria
individuals who referred to Atatürk University, Department of Periodontology
You may qualify if:
- Individuals should not have any systemic disease that may or may not require medication, including salivary gland pathologies, and not particularly thyroid organ pathologies.
- Individuals have not been continuously treated with anti-inflammatory, antioxidant or similar drugs in the last 6 months,
- Individuals have not received periodontal treatment until 6 months ago,
- Individuals must have at least 14 teeth
- Patients diagnosed with stage 3 periodontitis
You may not qualify if:
- Having a systemic disease such as cardiovascular, diabetes, hypertension, thyroid organ pathologies, chronic kidney failure
- Being pregnant/breastfeeding
- Being on medication for any reason
- Being a smoker/tobacco user
- Having another periodontal disease other than periodontitis
- Having a chronic inflammatory disease (COPD, asthma)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atatürk University
Erzurum, 25240_, Turkey (Türkiye)
Biospecimen
saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
DİDEM ÖZKAL EMİNOĞLU
Ataturk University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
June 21, 2023
First Posted
June 29, 2023
Study Start
August 1, 2023
Primary Completion
October 1, 2023
Study Completion
December 1, 2023
Last Updated
January 30, 2024
Record last verified: 2024-01